Table 2 Clinic outcomes of included patients.

From: Comparison of the safety and efficacy of dual antiplatelet therapy versus tenecteplase in patients with minor nondisabling acute ischemic stroke

 

DAPT (n = 31)

Tenecteplase (n = 31)

P

Primary outcome

 mRS score 0–1 at 90d

23 (74.2)

22 (71.0)

0.78

Secondary outcomes

 mRS score 0–2 at 90 d

30 (96.8)

28 (90.3)

0.31

 Length of hospital stay, median (IQR)

7.0 (6.0–10.0)

8.0 (6.0–12.0)

0.70

Safety outcomes

 Symptomatic intracerebral hemorrhage (sICH)

0

1 (3.2)

0.12

 Any bleeding events

0.01

  Major

0

0

 

  Minor

11 (3.2)

8 (25.8)

 
Back to article page